Emerging targets in osteoporosis disease modification.
Article Details
- CitationCopy to clipboard
Allen JG, Fotsch C, Babij P
Emerging targets in osteoporosis disease modification.
J Med Chem. 2010 Jun 10;53(11):4332-53. doi: 10.1021/jm9018756.
- PubMed ID
- 20218623 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Dinoprostone Prostaglandin E2 receptor EP1 subtype IC 50 (nM) 1.1 N/A N/A Details Dinoprostone Prostaglandin E2 receptor EP2 subtype IC 50 (nM) 37.7 N/A N/A Details Dinoprostone Prostaglandin E2 receptor EP3 subtype IC 50 (nM) 0.94 N/A N/A Details Dinoprostone Prostaglandin E2 receptor EP4 subtype IC 50 (nM) 9.9 N/A N/A Details